Delivery Order SPE2DX15D8003-SPE2DX22F7E5B

Award Date 6/21/22

Potential Completion Date 6/22/22

Potential Value $15K

Federal Agency

Medical Supply Chain

Awardee

Dakota Drug, Inc. H544BCGUKW64

Ultimate Awardee

Not listed

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Minot, ND, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

The federal contract award with ID SPE2DX15D8003|SPE2DX22F7E5B is for the delivery of STRATTERA 25 MG CAPSULE 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical division. The $15,210.42 firm fixed-price delivery order was awarded on June 21, 2022 to Dakota Drug, Inc., a self-certified small disadvantaged business, with a performance period ending on June 22, 2022. This award is associated with Dakota Drug, Inc.'s $999,999,999.00 Indefinite Delivery Contract (IDC) SPE2DB24D8001, which is part of the DLA Troop Support Medical's ECAT Generation V Program for providing pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has no set-aside designation, indicating Dakota Drug, Inc.'s competitive standing in the federal marketplace.

Generated 5/9/25, 9:47 AM